Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Cagrilintide represents a novel approach to obesity management
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
Maria Soler Nunez appointed as Chief Quality Officer
Vonvendi is the only recombinant Von Willebrand factor replacement therapy with approved indications in adults and children with VWD
The medicine was well tolerated, with no unexpected safety issue
Subscribe To Our Newsletter & Stay Updated
